₹77.34
as on
as on September 8, 2025 at 4:01 pm IST
Day's Low
Day's High
1.53%
Downside
1.85%
Upside
52 Week's Low
52 Week's High
9.36%
Downside
81.67%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹124.68 Cr
Return on Equity (ROE)
-6.15
PE Ratio (TTM)
-12.77
Return on capital employed (ROCE)
1.16
Industry PE ratio
42.41
Beta (LTM)
1.22
P/B Ratio
1.03
Dividend Yield
0PEG Ratio
1.23
Quarterly Earnings Growth YOY
-614.93
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on September 8, 2025 at 4:01 pm IST
Mangalam Drugs and Organics Ltd in the last 5 years
Lowest (-14.99x)
July 23, 2025
Today (-12.77x)
September 5, 2025
Industry (42.41x)
September 5, 2025
Highest (21.50x)
September 30, 2024
Today’s Price to Earnings Ratio: -12.77x
Compare market cap, revenue, PE, and other key metrics of Mangalam Drugs and Organics Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 124.68 | -9.19% | 0.72 | -10 | 368 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Mangalam Drugs and Organics Ltd Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:38% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Mangalam Drugs and Organics Ltd.
Mangalam Drugs and Organics Ltd’s net profit fell -614.93% since last year same period to ₹-13.80Cr in the Q1 2025-2026. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -23100% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2017, Mangalam Drugs and Organics Ltd has declared dividend of ₹0.50 per share on 12 Dec 2017 - translating a dividend yield of 0.63%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.47% to 0.53% in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 183.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.30% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 16.2% return, outperforming this stock by 56.0%
Retail Holding Down
Retail Investor have decreased holdings from 49.23% to 49.16% in Jun 2025 quarter
Price Dip
In the last 3 years, MANGALAM stock has moved down by -46.5%
Organisation | Mangalam Drugs and Organics Ltd |
Industry | Pharmaceuticals |
CEO | Govardhan M Dhoot |
E-voting on shares | Click here to vote |
Mangalam Drugs and Organics Ltd share price today stands at ₹77.34 as on at the close of the market. Mangalam Drugs and Organics Ltd share today touched a day high of ₹78.77 and a low of ₹76.16.
Mangalam Drugs and Organics Ltd touched a 52 week high of ₹140.5 and a 52 week low of ₹70.1. Mangalam Drugs and Organics Ltd share price today i.e. is closed at ₹77.34, which is -44.95% down from its 52 week high and 10.33% up from its 52 week low.
Mangalam Drugs and Organics Ltd market capitalisation is ₹124.68 Cr as on .
To buy Mangalam Drugs and Organics Ltd shares, you need to follow these steps:
Mangalam Drugs and Organics Ltd trading volume is 12.65K as on . This means that 12.65K shares of Mangalam Drugs and Organics Ltd were bought and sold on the stock market during today's trading session.